Sanofi-Aventis wins a round in US Eloxatin litigation, but generics shipping
14 September 2009
Nancy Faigen
Please Login to read the full article.
14 September 2009
Nancy Faigen
nancy.faigen@informausa.com
Sanofi-Aventis has won an appeals court ruling that reinstates patent infringement litigation brought against several generic drug makers regarding the innovator's chemotherapy medication Eloxatin (oxaliplatin).
The US Court of Appeals for the Federal Circuit on September 9th vacated and...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Settlement the best way forward in Sanofi-Aventis and Sun's Eloxatin spat?
- Lilly wins round in diabetes drug dispute with Amylin, but litigation continues
- Momenta falls on Amphastar’s generic Lovenox approval, and sues for infringement
- More generic competition for Sanofi's Eloxatin in Europe as Strides gets UK nod
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
